Articles tagged with Albumin
A tele-ICU service in Georgia reduced hospital transfers and saved $240,000 by providing guideline-recommended treatments within 24 hours. Researchers also found that serum albumin levels can help differentiate between types of shock, improving outcomes.
This study found that variations in plasma glutamyl transferase (GGT) and albumin (ALB) levels are genetically influenced and correlate with cardiovascular disease risk factors. The researchers identified chromosomal regions containing genes that affect GGT and ALB variation, which may also influence cardiovascular health.
Researchers have identified a contaminant in common intravenous treatments that can trigger life-threatening inflammation in critically ill patients. Advanced glycation end products, found in albumin infusion solutions, can cause significant inflammation and death rates in mice, suggesting the need for improved patient outcomes.
Researchers found that urinary albumin to creatine ratio is a powerful and independent predictor of heart failure prognosis, even in patients without diabetes or kidney disease. A high ratio was associated with increased risk of death from cardiovascular causes and hospital admission for worsening heart failure.
Researchers found a strong association between microalbuminuria and venous thromboembolism (VTE), including deep vein thrombosis and pulmonary embolism. Microalbuminuria was associated with a higher risk of VTE, even in the absence of traditional risk factors.
A study suggests that combining glomerular filtration rate (GFR) and urinary albumin levels can predict which patients with chronic kidney disease will develop end-stage renal disease. This combination test could help identify patients at high risk of serious kidney trouble.
Researchers at the University of Warwick have discovered that high doses of thiamine can dramatically decrease albumin excretion and reverse early-stage diabetic kidney disease. The study found that 300mg of thiamine taken orally daily for three months reduced albumin excretion by 41% in type 2 diabetes patients.
Researchers found that adding pressure early in their protocol dramatically speeds up proteomic analysis, reducing the time-consuming first step from four hours to just one minute. This breakthrough increases the number of samples that can be analyzed, with the pressure method generating about 10% more unique peptides.
A study found that higher levels of urinary albumin in healthy individuals, even within the considered normal range, increase the risk of developing hypertension. This suggests that kidney damage or endothelial dysfunction may be precursors to high blood pressure.
Researchers found that breakdown of self-cleaning mechanism in kidneys can lead to dysfunction and disease. The study suggests that defects in this clearance mechanism can cause accumulation of toxic substances, such as autoimmune antibodies, which can damage the kidney.
Researchers developed a new model to predict survival after liver transplantation, considering specific characteristics of donors and recipients. The model identified key factors impacting graft survival, including donor age and recipient MELD score.
Researchers found a significant negative correlation between urine albumin levels and adiponectin hormone in obese mice. In humans, low adiponectin levels were associated with albuminuria, an indicator of kidney disease.
A study published in the Canadian Medical Association Journal found that levels of ischemia-modified albumin provided no useful information in predicting which patients with potential acute coronary syndrome would experience serious cardiac outcomes. The analysis suggests that prognosis may precede diagnosis in these cases.
Researchers have discovered that serum albumin in Asian elephants plays a crucial role in transporting sex pheromones. The protein helps protect and extend the detection period of the pheromone, allowing successful mating to occur. This unique transport system is distinct from other mammalian pheromone transport systems.
Researchers found that high levels of C-reactive protein and low albumin are associated with a higher risk of cardiovascular disease in dialysis patients. The study, which followed over 1,000 patients for four months, found that these proteins can identify patients at high risk before heart events occur.
Researchers have made significant strides in artificial liver technology, with 20 patients using the albumin dialysis approach in a phase I trial. The system has shown promise in reducing blood toxins and reversing coma and shock, offering hope to those waiting for liver transplants.
Dialysis patients who took amino acid supplements experienced a significant increase in albumin levels, with an average rise of 0.22 g/dL for hemodialysis patients and 0.01 g/dL for peritoneal dialysis patients. This study suggests that simple nutritional interventions can have a positive impact on the health of dialysis patients.